Trial intelligence / Profile preview

Phase I/II study of ACYW135 meningococcal polysaccharide conjugate vaccine in participants aged 2 months to 59 years

CTR20232934Phase 2Active

Sponsor
Sino Biopharmaceutical Limited
Start
Sep 2023
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of A, C, Y, W135 meningococcal polysaccharide vaccine in meningococcal meningitis, sponsored by Sino Biopharmaceutical Limited. Started Sep 2023; status: active.

02

Drugs

A, C, Y, W135 meningococcal polysaccharide vaccine
03

Conditions

meningococcal meningitis

Beyond the preview

Go deeper on CTR20232934.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20232934.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call